Pines Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.82M Sell
5,035
-11
-0.2% -$3.77K 0.52% 46
2026
Q1
$1.78M Sell
5,046
-44
-0.9% -$15.7K 0.57% 37
2025
Q4
$1.67M Buy
5,090
+24
+0.5% +$7.61K 0.54% 44
2025
Q3
$1.43M Sell
5,066
-45
-0.9% -$13.1K 0.48% 50
2025
Q2
$1.52M Buy
5,111
+145
+3% +$41.1K 0.54% 41
2025
Q1
$1.39M Buy
4,966
+191
+4% +$56.4K 0.64% 36
2024
Q4
$1.25M Buy
+4,775
New +$1.42M 0.54% 44

Other funds holding AMGN

Pines Wealth Management's AMGN Position: Q2 2026 in Review

Pines Wealth Management reduced its Amgen (AMGN) stake by 0.22% in Q2 2026, selling an estimated $3.77K and leaving 5,035 shares worth $1.82M. The position accounts for 0.52% of the portfolio, ranked #46.

Pines Wealth Management first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. 1,055 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Pines Wealth Management held 5,035 shares of Amgen worth $1.82M as of Q2 2026.
  • Pines Wealth Management sold 11 Amgen shares in Q2 2026, an estimated $3.77K.
  • Amgen made up 0.52% of Pines Wealth Management's portfolio in Q2 2026, its #46 holding.
  • Pines Wealth Management first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • 1,055 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Pines Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.